You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the first-line treatment of chronic lymphocytic leukaemia

  • Technology appraisal guidance
  • Reference number: TA174
  • Published:  22 July 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Information for the public

  • Rituximab for the first-line treatment of chronic lymphocytic leukaemia (PDF 59 KB)

    Published:
    22 July 2009
  • Gwybodaeth i'r cyhoedd (Word 239 KB)

    Published:
    16 November 2009
Back to top